Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,775 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of Circulating lncRNAs Associated with Gallbladder Cancer Risk by Tissue-Based Preselection, Cis-eQTL Validation, and Analysis of Association with Genotype-Based Expression.
Blandino A, Scherer D, Rounge TB, Umu SU, Boekstegers F, Barahona Ponce C, Marcelain K, Gárate-Calderón V, Waldenberger M, Morales E, Rojas A, Munoz C, Retamales J, de Toro G, Barajas O, Rivera MT, Cortés A, Loader D, Saavedra J, Gutiérrez L, Ortega A, Bertrán ME, Gabler F, Campos M, Alvarado J, Moisán F, Spencer L, Nervi B, Carvajal-Hausdorf DE, Losada H, Almau M, Fernández P, Gallegos I, Olloquequi J, Fuentes-Guajardo M, Gonzalez-Jose R, Bortolini MC, Gallo C, Linares AR, Rothhammer F, Lorenzo Bermejo J. Blandino A, et al. Among authors: fernandez p. Cancers (Basel). 2022 Jan 27;14(3):634. doi: 10.3390/cancers14030634. Cancers (Basel). 2022. PMID: 35158906 Free PMC article.
Development and internal validation of a multifactorial risk prediction model for gallbladder cancer in a high-incidence country.
Boekstegers F, Scherer D, Barahona Ponce C, Marcelain K, Gárate-Calderón V, Waldenberger M, Morales E, Rojas A, Munoz C, Retamales J, de Toro G, Barajas O, Rivera MT, Cortés A, Loader D, Saavedra J, Gutiérrez L, Ortega A, Bertrán ME, Bartolotti L, Gabler F, Campos M, Alvarado J, Moisán F, Spencer L, Nervi B, Carvajal-Hausdorf D, Losada H, Almau M, Fernández P, Olloquequi J, Fuentes-Guajardo M, Gonzalez-Jose R, Bortolini MC, Acuña-Alonzo V, Gallo C, Linares AR, Rothhammer F, Lorenzo Bermejo J. Boekstegers F, et al. Among authors: fernandez p. Int J Cancer. 2023 Sep 15;153(6):1151-1161. doi: 10.1002/ijc.34607. Epub 2023 Jun 1. Int J Cancer. 2023. PMID: 37260300
Gallbladder Cancer Risk and Indigenous South American Mapuche Ancestry: Instrumental Variable Analysis Using Ancestry-Informative Markers.
Zollner L, Boekstegers F, Barahona Ponce C, Scherer D, Marcelain K, Gárate-Calderón V, Waldenberger M, Morales E, Rojas A, Munoz C, Retamales J, De Toro G, Kortmann AV, Barajas O, Rivera MT, Cortés A, Loader D, Saavedra J, Gutiérrez L, Ortega A, Bertrán ME, Bartolotti L, Gabler F, Campos M, Alvarado J, Moisán F, Spencer L, Nervi B, Carvajal D, Losada H, Almau M, Fernández P, Olloquequi J, Carter AR, Miquel Poblete JF, Bustos BI, Fuentes Guajardo M, Gonzalez-Jose R, Bortolini MC, Acuña-Alonzo V, Gallo C, Ruiz Linares A, Rothhammer F, Lorenzo Bermejo J. Zollner L, et al. Among authors: fernandez p. Cancers (Basel). 2023 Aug 9;15(16):4033. doi: 10.3390/cancers15164033. Cancers (Basel). 2023. PMID: 37627062 Free PMC article.
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial.
Kelley RK, Ueno M, Yoo C, Finn RS, Furuse J, Ren Z, Yau T, Klümpen HJ, Chan SL, Ozaka M, Verslype C, Bouattour M, Park JO, Barajas O, Pelzer U, Valle JW, Yu L, Malhotra U, Siegel AB, Edeline J, Vogel A; KEYNOTE-966 Investigators. Kelley RK, et al. Lancet. 2023 Jun 3;401(10391):1853-1865. doi: 10.1016/S0140-6736(23)00727-4. Epub 2023 Apr 16. Lancet. 2023. PMID: 37075781 Clinical Trial.
SNAPSHOT USA 2021: A third coordinated national camera trap survey of the United States.
Shamon H, Maor R, Cove MV, Kays R, Adley J, Alexander PD, Allen DN, Allen ML, Appel CL, Barr E, Barthelmess EL, Baruzzi C, Bashaw K, Bastille-Rousseau G, Baugh ME, Belant J, Benson JF, Bespoyasny BA, Bird T, Bogan DA, Brandt LSE, Bresnan CE, Brooke JM, Buderman FE, Buzzell SG, Cheeseman AE, Chitwood MC, Chrysafis P, Collins MK, Collins DP, Compton JA, Conner LM, Cosby OG, Coster SS, Crawford B, Crupi AP, Darracq AK, Davis ML, DeGregorio BA, Denningmann KL, Dougherty KD, Driver A, Edelman AJ, Ellington EH, Ellis-Felege SN, Ellison CN, Fantle-Lepczyk JE, Farris ZJ, Favreau J, Fernandez P, Fisher-Reid MC, Fitzpatrick MC, Flaherty EA, Forrester TD, Fritts SR, Gallo T, Gerber BD, Giery ST, Glasscock JL, Gonatas AD, Grady AC, Green AM, Gregory T, Griffin N, Hagen RH, Hansen CP, Hansen LP, Hasstedt SC, Hernández-Yáñez H, Herrera DJ, Horan RV 3rd, Jackson VL, Johnson L, Jordan MJ, Kahano W, Kiser J, Knowles TW, Koeck MM, Koroly C, Kuhn KM, Kuprewicz EK, Lafferty DJR, LaPoint SD, Lashley M, Lathrop RG, Lee TE Jr, Lepczyk CA, Lesmeister DB, Lombardi JV, Long RA, Lonsinger RC, MacKay P, Maher SP, Mason DS, Millspaugh JJ, Moll RJ, Moon JB, Mortelliti A, Mychajliw AM, Nagy CM, Neiswente… See abstract for full author list ➔ Shamon H, et al. Among authors: fernandez p. Ecology. 2024 May 1:e4318. doi: 10.1002/ecy.4318. Online ahead of print. Ecology. 2024. PMID: 38693703
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
Choueiri TK, Tomczak P, Park SH, Venugopal B, Ferguson T, Symeonides SN, Hajek J, Chang YH, Lee JL, Sarwar N, Haas NB, Gurney H, Sawrycki P, Mahave M, Gross-Goupil M, Zhang T, Burke JM, Doshi G, Melichar B, Kopyltsov E, Alva A, Oudard S, Topart D, Hammers H, Kitamura H, McDermott DF, Silva A, Winquist E, Cornell J, Elfiky A, Burgents JE, Perini RF, Powles T; KEYNOTE-564 Investigators. Choueiri TK, et al. N Engl J Med. 2024 Apr 18;390(15):1359-1371. doi: 10.1056/NEJMoa2312695. N Engl J Med. 2024. PMID: 38631003 Clinical Trial.
1,775 results